Hair aging solutions with advanced in vitro screening
QIMA Life Sciences offers advanced in vitro screening solutions for hair aging research, utilizing expertise in hair biology and isolated hair models. Our technology supports primary and secondary screening to differentiate compounds effectively.
Overview
QIMA Life Sciences specializes in providing cutting-edge in vitro screening solutions for hair aging research. Leveraging over a decade of expertise in hair biology, our platform uses isolated hair and various cell types such as dermal papilla cells, keratinocytes, and sebocytes. These solutions enable researchers to screen and differentiate compounds effectively, addressing various research targets with precision.
Technical specifications
Our technology includes:
- In vitro 2D solutions for primary compound screening, ideal for initial phases of research.
- Isolated hair solutions for secondary screening using the Philpott model, allowing for in-depth analysis and validation.
- Capability to access human hair samples regularly through established networks.
- Versatile methodologies that permit multiple readouts from a single sample, offering comprehensive insights.
Technology readiness level
Our hair aging solutions are at Technology Readiness Level 9, indicating that the technology has been fully validated and is ready for commercial application in research and development settings.
About QIMA Lifesciences
QIMA Life Sciences is a specialized Contract Research Organization (CRO) and CDMO providing end-to-end research and testing services for the pharmaceutical, biotech, and cosmetic industries. The organization operates through a network of specialized laboratories, including entities such as QIMA Bioalternatives, QIMA Newtone, QIMA Monasterium, QIMA Skinpharma, and Oxiproteomics. Their scientific capabilities encompass in vitro, ex vivo, and clinical evaluation, utilizing advanced analytical platforms to support drug discovery, efficacy substantiation, and safety testing from early development stages through to clinical trials. By integrating multidisciplinary expertise in cellular and molecular pharmacology, dermatology, and image processing, they deliver customized, science-driven strategies designed to accelerate development timelines and optimize research outcomes for global clients.
These services are critical for partners seeking to substantiate product claims, improve the success rates of drug candidates, or navigate complex regulatory environments. QIMA Life Sciences leverages state-of-the-art facilities—including over 10,000 square meters of laboratory space and clinical infrastructure equipped for Phase I to IV trials—to provide robust, regulatory-aligned data. With nearly 30 years of experience and a team of over 600 professionals, the organization supports clients in making data-backed R&D decisions. Their commitment to innovation is evidenced by extensive scientific output, including hundreds of published works, which helps clients in the beauty, healthcare, and veterinary sectors ensure their products meet rigorous quality and performance standards.
delivered to your inbox.